Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division.
Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.
Education History
| Graduate Training |
Vanderbilt University Epidemiology, Biostatistics, Clinical Research Design, etc |
M.P.H. |
|---|---|---|
| Fellowship |
Vanderbilt University Medical Center Epilepsy/Neurophysiology |
Clinical Fellow |
| Chief Resident |
Vanderbilt University Medical Center Neurology |
Chief Resident |
| Residency |
Vanderbilt University Medical Center Neurology |
Resident |
| Internship |
McLaren Flint Internal Medicine |
Intern |
| Professional Medical |
Dow Medical College of the University of Karachi Medicine, Surgery |
M.B.B.S. |